Jump to Navigation Skip to main content

Awards & Funding

Education

Events

Research

Newsroom

“This is the first time that a human gene has been linked to a better recovery from stroke,” said the study's senior author Dr. S. Thomas Carmichael.

A missing gene makes a big difference in patients’ recovery from mild stroke

Microscopic images of a normal heart valve in a mouse, left, and a heart valve grown in a lab with heart-derived macrophages blocked, right. Without those macrophages, the valves are thick and deformed.

Scientists discover new type of immune cells that are essential for forming heart valves

Research by UCLA’s Gay Crooks, Amélie Montel-Hagen and Christopher Seet could point the way toward “off-the-shelf” T cell therapies that are more readily available to patients.

UCLA scientists create a renewable source of cancer-fighting T cells

Led by Dr. Donald Kohn and Katelyn Masiuk, the researchers engineered a “viral vector” that would turn on the FoxP3 gene only in regulatory T cells — and not in other types of cells.

UCLA researchers correct genetic mutation that causes IPEX, a life-threatening autoimmune syndrome

tumor comparison showing lactate dehydrogenase activity

UCLA study overturns dogma of cancer metabolism theory – tumors not as addicted to glucose as previously thought

UCLA scientists elected to the American Society for Clinical Investigation

UCLA researcher Michael Carey (middle) guides his team in the lab

Study identifies location of DNA that gives clues to hidden cancer mutations

Investigators study how a protein factor involved in making messenger RNA molecules also contributes to cancer cell migration

Patient-specific human induced pluripotent stem cell-derived retinal pigment epithelium cells

$5.1 million grant will fund research to develop a stem cell-based therapy for blinding eye conditions

Microscopic image of small cell neuroendocrine prostate cancer: cancer cells are seen expressing diagnostic prostate cancer markers in green and red (blue color indicates the cell nucleus).

UCLA researchers discover aggressive prostate and lung cancers are driven by common mechanisms

Pages